Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSenseâ„¢, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...
In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...
Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...
With a fresh infusion of personality, smarts and expertise, a new Alexa − officially, Alexa+ − is about to transform Amazon’s smart home control center from simple command-taker to a perky ...
In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in ...
Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback